NCT00825981

Primary and Secondary Hemostasis in Elective Coronary Artery Bypass Graft Surgery

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

Patients undergoing elective coronary artery bypass graft surgery (CABG) are treated with platelet inhibitors to reduce myocardial infarction and mortality.However, this can increase perioperative bleeding. A retrospective analysis of the data in our institution has revealed a significant increase in transfusion requirements after elective CABG since 5 years. The aim of our study is to observe if this increase in transfusion requirements is due to platelet inhibitors or due to other coagulation abnormalities resulting from other anticoagulants.

Conditions

• Coronary Disease

Interventions

Type	Name	Description
OTHER	screening coagulation abnormalities	if specific coagulation abnormalities are observed which increase patient's risk of bleeding, appropriate treatment will start

Timeline

• Start date: 2009-01-01
• Primary completion: 2010-01-01
• Completion: 2010-03-01
• First posted: 2009-01-21
• Last updated: 2010-07-23

Locations

1 site across 1 country: Belgium